Evidence map›Paper›PMID 16995858›Full record

ArticleThe FEBS journal2006

Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma.

Daniel E Alete, Mark E Weeks, Ara G Hovanession, Muhamed Hawadle, Andrew W Stoker

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cell surface nucleolin interacts with CXCR4 receptor via the 212 c-terminal portion.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  5. Article
  6. Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  7. Article
  8. PTPBR7 binding proteins in myelinating neurons of the mouse brain.International journal of biological sciences · 2011
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. alpha-Latrotoxin and its receptors.Handbook of experimental pharmacology · 2008
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Daniel E AleteNeural Development Unit, Institute of Child Health, University College London, UK.
Mark E Weeks
Ara G Hovanession
Muhamed Hawadle
Andrew W Stoker
University College London · GBDélégation Paris 5 · FR

Funding

Wellcome Trust 071418
6 · The paper itself

Abstract

Reversible tyrosine phosphorylation, catalyzed by receptor tyrosine kinases and receptor tyrosine phosphatases, plays an essential part in cell signaling during axonal development. Receptor protein tyrosine phosphatase-sigma has been implicated in the growth, guidance and repair of retinal axons. This phosphatase has also been implicated in motor axon growth and innervation. Insect orthologs of receptor protein tyrosine phosphatase-sigma are also implicated in the recognition of muscle target cells. A potential extracellular ligand for vertebrate receptor protein tyrosine phosphatase-sigma has been previously localized in developing skeletal muscle. The identity of this muscle ligand is currently unknown, but it appears to be unrelated to the heparan sulfate ligands of receptor protein tyrosine phosphatase-sigma. In this study, we have used affinity chromatography and tandem MS to identify nucleolin as a binding partner for receptor protein tyrosine phosphatase-sigma in skeletal muscle tissue. Nucleolin, both from tissue lysates and in purified form, binds to receptor protein tyrosine phosphatase-sigma ectodomains. Its expression pattern also overlaps with that of the receptor protein tyrosine phosphatase-sigma-binding partner previously localized in muscle, and nucleolin can also be found in retinal basement membranes. We demonstrate that a significant amount of muscle-associated nucleolin is present on the cell surface of developing myotubes, and that two nucleolin-binding components, lactoferrin and the HB-19 peptide, can block the interaction of receptor protein tyrosine phosphatase-sigma ectodomains with muscle and retinal basement membranes in tissue sections. These data suggest that muscle cell surface-associated nucleolin represents at least part of the muscle binding site for axonal receptor protein tyrosine phosphatase-sigma and that nucleolin may also be a necessary component of basement membrane binding sites of receptor protein tyrosine phosphatase-sigma.

Indexed as

Amino Acid SequenceAnimalsAxonsCells, CulturedChick EmbryoLactoferrinLigandsMembrane ProteinsMolecular Sequence DataMuscle Fibers, SkeletalMuscle, SkeletalNucleolinPeptidesPhosphoproteinsProtein BindingProtein Tyrosine PhosphatasesHB-19 peptideLactoferrinLigandsMembrane ProteinsNucleolinPeptidesPhosphoproteinsProtein Tyrosine PhosphatasesReceptor-Like Protein Tyrosine Phosphatases, Class 2RNA-Binding Proteins

Identifiers

PMID16995858
PMCPMC1866192
OpenAlexW1536030981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.